Psomagen (XKRX:950200) Total Stockholders Equity : ₩31,397 Mil (As of Jun. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Psomagen Total Stockholders Equity?

Psomagen's Total Stockholders Equity for the quarter that ended in Jun. 2024 was ₩31,397 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Psomagen's Book Value per Share for the quarter that ended in Jun. 2024 was ₩1,632.20. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Psomagen's Debt-to-Equity for the quarter that ended in Jun. 2024 was 0.32.

Psomagen Total Stockholders Equity Historical Data

The historical data trend for Psomagen's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psomagen Total Stockholders Equity Chart

Psomagen Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

-18,893.61

37,242.36

34,145.56

35,683.45

32,220.26

Psomagen Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Total Stockholders Equity	Get a 7-Day Free Trial															35,566.77	35,076.28	32,220.26	31,889.60	31,397.09

Psomagen (XKRX:950200) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Psomagen's Book Value per Share for the quarter that ended in Jun. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(31397.091	-	0)	/	19.236
	=	1,632.20

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Psomagen's Debt-to-Equity for the quarter that ended in Jun. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2065.846	+	7902.516)	/	31397.091
	=	0.32

Psomagen Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Psomagen's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Psomagen Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Psomagen Inc (XKRX:950200) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

1330 Piccard Drive, Suite 103, Rockville, MD, USA, 20850

Website

https://www.psomagen.com

Psomagen Inc provides total genomic solutions for both clinical and research purposes. It is mainly focused on end-to-end sequencing services. The company also offers services such as personal DNA tests, clinical sequencing, research sequencing, and others.

Psomagen Headlines

No Headlines